OUP Management »

Effector Therapeutics shares owned by OUP Management

Quarter-by-quarter ownership of Effector Therapeutics shares owned by OUP Management from 13F filings

Historical chart of OUP Management investment in Effector Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Effector Therapeutics held by OUP Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Effector Therapeutics by OUP Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $615k 1.0M 0.60
2023-06-30 $852k 1.0M 0.83
2023-03-31 $362k 1.0M 0.35
2022-12-31 $439k 1.0M 0.43
2022-09-30 $587k 1.0M 0.57
2022-06-30 $1.5M 1.0M 1.42
2022-03-31 $4.1M 1.0M 4.01
2021-12-31 $8.5M 1.0M 8.28

More positions owned by OUP Management

Centessa Pharmaceuticals Sponsored ADS (CNTA)
Aerovate Therapeutics Common Stock (AVTE)
Cyteir Therapeutics Common Stock
PMV Pharmaceuticals Common Stock (PMVP)
Graphite Bio Common Stock
Selecta Biosciences Common Stock
Vor Biopharma Common Stock (VOR)
eFFECTOR Therapeutics Common Stock
Precision BioSciences Common Stock
Spero Therapeutics Common Stock (SPRO)
Ikena Oncology Common Stock (IKNA)
Homology Medicines Common Stock

View all positions for OUP Management

Top funds holding Effector Therapeutics

Blackstone Group

View all funds holding Effector Therapeutics